These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 20453081
1. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Ahtiainen P, Sharp V, Rulli SB, Rivero-Müller A, Mamaeva V, Röyttä M, Huhtaniemi I. Endocr Relat Cancer; 2010 Sep; 17(3):611-21. PubMed ID: 20453081 [Abstract] [Full Text] [Related]
2. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1. Faraoni EY, Camilletti MA, Abeledo-Machado A, Ratner LD, De Fino F, Huhtaniemi I, Rulli SB, Díaz-Torga G. J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433 [Abstract] [Full Text] [Related]
6. Pituitary prolactin-secreting tumor formation: recent developments. Xu RK, Wu XM, Di AK, Xu JN, Pang CS, Pang SF. Biol Signals Recept; 2000 Mar; 9(1):1-20. PubMed ID: 10686432 [Abstract] [Full Text] [Related]
7. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Kuorelahti A, Rulli S, Huhtaniemi I, Poutanen M. Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243 [Abstract] [Full Text] [Related]
8. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development. Kuchenbauer F, Theodoropoulou M, Hopfner U, Stalla J, Renner U, Tonn JC, Low MJ, Arzt E, Stalla GK, Páez-Pereda M. Mol Cell Endocrinol; 2003 Sep 30; 207(1-2):13-20. PubMed ID: 12972179 [Abstract] [Full Text] [Related]
9. Pituitary gonadotrophin secretion during the first weeks of pregnancy. Jeppsson S, Rannevik G, Thorell JI. Acta Endocrinol (Copenh); 1977 May 30; 85(1):177-88. PubMed ID: 324219 [Abstract] [Full Text] [Related]
10. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I. Endocrinology; 2002 Oct 30; 143(10):4084-95. PubMed ID: 12239120 [Abstract] [Full Text] [Related]
11. Reexpression of p8 contributes to tumorigenic properties of pituitary cells and appears in a subset of prolactinomas in transgenic mice that hypersecrete luteinizing hormone. Mohammad HP, Seachrist DD, Quirk CC, Nilson JH. Mol Endocrinol; 2004 Oct 30; 18(10):2583-93. PubMed ID: 15243129 [Abstract] [Full Text] [Related]
14. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D. Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350 [Abstract] [Full Text] [Related]
15. Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. Genazzani AR, Petraglia F, Silferi M, Lattesa AM, Coukos G, Genazzani AD, Artini P, Nappi C, Volpe A. Gynecol Obstet Invest; 1990 Jan 12; 29(3):197-202. PubMed ID: 2141585 [Abstract] [Full Text] [Related]